iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, will present updated clinical data, host in-booth clinician presentations and showcase the latest in radiation technology at the American Society for Radiation Oncology (ASTRO) meeting in San Antonio, TX from October 18-21, 2015.

Layering brief radiologist training sessions atop feedback-enabled dose tracking, researchers at Children’s Hospital of Pittsburgh have shown that it’s possible to cut radiation exposure to pediatric patients almost in half. 

Retroactively implementing ACR’s 2014 LungRADS classification criteria, an academic medical center increased the positive predictive value in a CT lung-screening cohort of more than 1,600 patients by a factor of 2.5—without driving an increase in surgeries following false negatives.

Efforts to curb the overutilization of imaging have been a topic of discussion for a number of years, spurred by the growth of imaging in the mid-2000s. But what can’t be forgotten is the value imaging brings to patient care. 

Another study has found reduced recall rates, along with increased cancer detection, for patients who undergo 3D digital breast tomosynthesis (DBT) rather than standard 2D mammography at screening. 

European researchers have discovered a class of molecule that, when exposed to the inert gas xenon, enables MRI contrast significantly sharper than previous contrast techniques.

CT scans in the emergency department (ED) often lead to key changes in clinical decisionmaking for symptoms commonly seen in ED visits, according to a study published in Radiology. 

Breast cancer treatments are improving and prognoses more positive overall, but, even at this advanced stage of the high-tech “war on cancer,” early diagnosis and staging are still of the essence.